|
论文标题：Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries 作者：Freddie Bray, Mathieu Laversanne, Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Isabelle Soerjomataram, Ahmedin Jemal 期刊：CA: A Cancer Journal for Clinicians 发表时间：2024/04/04 数字识别码：10.3322/caac.21834 摘要：This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally), followed by cancers of the female breast (11.6%), colorectum (9.6%), prostate (7.3%), and stomach (4.9%). Lung cancer was also the leading cause of cancer death, with an estimated 1.8 million deaths (18.7%), followed by colorectal (9.3%), liver (7.8%), female breast (6.9%), and stomach (6.8%) cancers. Breast cancer and lung cancer were the most frequent cancers in women and men, respectively (both cases and deaths). Incidence rates (including NMSC) varied from four-fold to five-fold across world regions, from over 500 in Australia/New Zealand (507.9 per 100,000) to under 100 in Western Africa (97.1 per 100,000) among men, and from over 400 in Australia/New Zealand (410.5 per 100,000) to close to 100 in South-Central Asia (103.3 per 100,000) among women. The authors examine the geographic variability across 20 world regions for the 10 leading cancer types, discussing recent trends, the underlying determinants, and the prospects for global cancer prevention and control. With demographics-based predictions indicating that the number of new cases of cancer will reach 35 million by 2050, investments in prevention, including the targeting of key risk factors for cancer (including smoking, overweight and obesity, and infection), could avert millions of future cancer diagnoses and save many lives worldwide, bringing huge economic as well as societal dividends to countries over the forthcoming decades. 查看更多 摘要翻译（由计算机程序完成，仅供参考，内容以英文原文为准）： 本文根据国际癌症研究机构（IARC）的最新估计，介绍了2022年按世界地区划分的癌症全球统计数据。2022年，癌症新增病例近2000万例（包括非黑色素瘤皮肤癌），癌症死亡病例970万例（包含非黑色素癌）。据估计，大约五分之一的男性或女性一生中会患上癌症，而大约九分之一的女性和九分之一死于癌症。癌症是2022年诊断最频繁的癌症，导致了近250万例新病例，或全世界八分之一的癌症（占全球所有癌症的12.4%），其次是女性乳腺癌（11.6%）、结肠癌（9.6%）、前列腺癌（7.3%）和胃癌（4.9%）。癌症也是癌症死亡的主要原因，估计有180万人死亡（18.7%），其次是结直肠癌（9.3%）、肝癌（7.8%）、女性乳腺癌（6.9%）和胃癌（6.8%）。癌症和癌症分别是女性和男性最常见的癌症（包括病例和死亡）。世界各地区的发病率（包括NMSC）从四倍到五倍不等，从澳大利亚/新西兰的500多人（每100000人中有507.9人）到西非的100人以下（每100000万人中有97.1人），从澳大利亚和新西兰的400多人（十万人中有410.5人）到中南亚的近100人（十万分之103.3人）。作者研究了世界20个地区10种主要癌症类型的地理变异性，讨论了最近的趋势、潜在的决定因素以及全球癌症预防和控制的前景。基于人口学的预测表明，到2050年，癌症新增病例将达到3500万例，对预防的投资，包括针对癌症的关键风险因素（包括吸烟、超重和肥胖以及感染），可以避免未来数百万例癌症诊断，挽救世界各地许多人的生命，在未来几十年为各国带来巨大的经济和社会红利。 查看更多 |
